Laboratory Studies May Explode Long Held Belief Regarding VD
|Save page Remove page||Previous||1 of 1||Next|
small (250x250 max)
medium (500x500 max)
large ( > 500x500)
Indicate Germs Can Live in Air— Laboratory Studies May Explode Long Held Belief Regarding VD By MERRILEE LEATHERMAN Journal Staff Writer Lab studies at the Center for Disease Control in Atlanta indicate that certain strains of gonococcus can survive for as long as t h r e e days after exposure to air, physicians attending a seminar yesterday at Confederate M e m o r i a l Medical Center were told. This contradicts the long-held belief that gonococcus — the germ causing gonorrhea — dies shortly after exposure to the air. E M I L KOTCHER, Sc.D., professor and head, Depart-m e n t of Microbiology and lmmunioiogy, LSU School of Medicine in Shreveport, said a laboratory diagnosis is impor-tant to accurately determine whether or not a person has gonorrhea, particularly for women in whom the disease is difficult to detect in the early stages. Laboratory tests such as the Thayer-Martin, Oxydase and sugar fermentation, can deter-mine which strain of gonor-rhea has infected the person. For proper r e s u l t s , said Kotcher, culture specimens should be taken both from the cervix and anal canal in women and from the anterior urethra in men. In homosex-ual males, additional culture specimens from the anal canal and pharynx are recom-mended. DR. FENIMORE T. John-son, Director of Medical Af-fairs, The Upjohn Co., Kalam-azoo, Mich., said that penicil-lin remains the treatment of choice for uncomplicated gon-orrhea — the most prevalent major veneral disease in the United States. Dr. Johnson said that specti-n o;m y c i n hydrochloride, a newly marketed antibiotic, has. great promise for gonor-rhea treatment of the future. However, he added, penicillin given in the recommended dosage of 2.4 million units in one injection for men and 4.8 million units, divided in two injections, for women, has an added bonus of aborting pre-clinical syphilis. HE CAUTIONED physicians to-avoid long-acting, low doses of penicillin if treatment is to be effective. Dr. John Lewis, head of the Communicable Disease Divi-sion of the Louisiana State Department of Health in New Orleans, said a, statewide fight against gonorrhea is sched-uled to begin April 1. Dr. Lewis announced that the department will receive $320,000 a year for the next five years in an effort to improve the state's gonorrhea program. THE TWO MAJOR thrusts of the program, he said, will be to offer culture services so that tests may be properly handled and to have treat-ment available to those need-ing it. He added that it is hoped gonorrhea testing will become a routine part of all p e l v i c examinations per formed by physicians, health clinics and state hospitals. Included in the plans are a statewide p u b l i c education program. Also discussed at yester-day's seminar was Prostag-landins, a recent class drug development that seems to hav3 numerous possibilities. DR. JOHNSON, a pioneer in this field, said that prostag-landin is a naturally occurring chemical compound found in the body whch may be the most potent of known biologi-cal activities. At present, 14 prostaglandin agents are known, but, he said, there may be more. It is thought that the role of prostaglandin is to regulate or act as a monitor of enzymes and hormones at the cell level. Studies by both British and United States teams indicate the agent's future use in inducing labor. Double-blind clinical findings have shown that Prostaglandin F, alpha, can s a f e l y and effectively induct labor. OTHER AVENUES BEING explored, he said, include the stimulation of smooth tissue m u s c l e , the relaxation of bronchial muscles to aid ash-matics, dysmenorrhea control and regulation of blood pres-sure. Prostaglandin also is being viewed in relation to fertility and infertility marriage prob-lems. Recent studies, Dr. Johnson said, involved 'scare' preg nancies in which the drug was used to bring on the men-strual period. The most ob-vious destination of prostag-landin, he said, may lie in the "once-a-month, need it or not" treatment to prevent concep-tion. AH therapeutic avenues are being explored, he said, but reminded physicians that the drug probably will not be available for use in the United States for several years.
|Title||Laboratory Studies May Explode Long Held Belief Regarding VD|
Johnson, Fenimore T.
|Identifier||See reference URL on the navigation bar.|
|Source||Louisiana State University Health Sciences Center Shreveport Medical Library (http://lib.sh.lsuhsc.edu)|
|Coverage-Spatial||Shreveport (Caddo, La.)|
|Rights||Physical rights are retained by Louisiana State University Health Sciences Center Shreveport. Copyright is retained in accordance with U.S. copyright laws.|
Laboratory Studies May Explode Long Held Belief Regarding VDfor